In PAK4KO tumours, this pathway’s activation may further compensate for diminished VEGFA signalling, promoting alternative vascular strategies that sustain perfusion and contribute to the observed pro-angiogenic and VM phenotypes. The gene discussed is VEGFA; the disease is neoplasm.